Multibagger stock surges 606% in 5 years, fixes record date for 1:2 rights issue
Suven Life Sciences Ltd is a small-cap company with a market capitalization of 1,028.58 crore that operates in the pharmaceutical industry12-10-2022
12-10-2022
SUVEN LIFE SCIENCES LTD. - 530239 - Intimation Of Record Date For Rights Issue Of Suven Life Sciences Limited
This is to inform that the Rights Issue committee of the Board of Directors at its meeting held today i.e. October 12, 2022 has fixed Tuesday, October 18, 2022 as the 'Record Date' for the purpose of determining the equity shareholders entitled to receive rights entitlements in the Rights Issue of the Company approved by the Board of Directors at its meeting held on June 24, 2022 on the terms & conditions as approved by the Rights Issue committee of Board of Directors on October 12, 2022.12-10-2022
SUVEN LIFE SCIENCES LTD. - 530239 - Board Meeting Outcome for Outcome Of The Meeting Of The Rights Issue Committee Of Board Of Directors Of Suven Life Sciences Limited Held Today I.E. October 12, 2022.
Rights Issue Committee of the Board of Directors of the Company, at their meeting held today i.e. on October 12, 2022, inter-alia, considered and approved the following terms and conditions of the Rights issue.12-10-2022
SUVEN LIFE SCIENCES LTD. - 530239 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
This is to inform that the details of securities dematerialized/ rematerialized during the quarter ended September 30, 2022, as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, have been furnished by KFin Technologies Limited, Registrar & Transfer Agent (RTA) of the Company to the stock exchanges where the shares of the Company are listed. Letters confirming this from KFin Technologies Limited dated October 11, 2022 are enclosed for your reference.11-10-2022
SUVEN LIFE SCIENCES LTD. - 530239 - Board Meeting Intimation for Intimation Of The Meeting Of The Rights Issue Committee Of Board Of Directors Of Suven Life Sciences Limited To Be Held On Wednesday, October 12, 2022.
SUVEN LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/10/2022 ,inter alia, to consider and approve We inform you that a meeting of the Rights Issue Committee of the Board of Directors of the Company will be held on Wednesday, October 12, 2022 to, inter alia, consider and approve the terms and conditions of the rights issue including determination of the issue price and record date for the issuance of equity shares to be offered in the rights issue.07-10-2022
SUVEN LIFE SCIENCES LTD. - 530239 - Closure of Trading Window
We wish to inform that the "Trading Window" for dealing in the securities of the Company will be closed for the Designated Persons, their immediate relatives covered under the said Code of the Company from 1st October, 2022 and the same will remain closed till 48 hours after the declaration of Financial Results for the quarter ending 30th September, 2022, to the public, in terms of the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015. This is for your information and record.30-09-2022
SUVEN LIFE SCIENCES LTD. - 530239 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Suven Life Sciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here04-08-2022
SUVEN LIFE SCIENCES LTD. - 530239 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
This is with reference to our earlier letter dated 11th July, 2022 regarding the 33rd Annual General Meeting (AGM) of the Company held today i.e. Thursday, 04th August, 2022 and the business mentioned in the Notice dated 24th June, 2022 was transacted. In this regard, please find enclosed the following: 1. Summary of proceedings as required under the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure - I 2. Voting Results as required under Regulation 44 of the SESI (Listing Obligations and Disclosure Requirements) Regulations 2015 as Annexure- II 3. The Report of Scrutinizer on remote e-voting and voting at AGM (by electronic means) as Annexure- III04-08-2022
SUVEN LIFE SCIENCES LTD. - 530239 - Shareholder Meeting / Postal Ballot-Outcome of AGM
This is with reference to our earlier letter dated 11th July, 2022 regarding the 33rd Annual General Meeting (AGM) of the Company held today i.e. Thursday, 04th August, 2022 and the business mentioned in the Notice dated 24th June, 2022 was transacted. In this regard, please find enclosed the following: 1. Summary of proceedings as required under the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure - I 2. Voting Results as required under Regulation 44 of the SESI (Listing Obligations and Disclosure Requirements) Regulations 2015 as Annexure- II 3. The Report of Scrutinizer on remote e-voting and voting at AGM (by electronic means) as Annexure- III04-08-2022
SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed the copies of the newspaper advertisement regarding Un-audited Financial Results of the Company for quarter ended 30th June, 2022. The advertisements are as appeared on 27th July, 2022 in Business Standard and Andhra Prabha (Telugu).27-07-2022